|
|
PERPUSTAKAAN SEKOLAH TINGGI ILMU KESEHATAN SAMARINDA REPOSITORY
|
|
Select Language
Simple Search
Advanced Search
License
This Software is Released Under GNU GPL License
Version 3.
indexed
Visitors
Statistic
|
| Title |
Marmara Pharmaceutical Journal of Research in Pharmacy Journal of Research in Pharmacy 2021 , Vol 25 Issue 5 |
| Edition |
2021 , Vol 25 Issue 5 |
| Call Number |
|
| ISBN/ISSN |
|
| Author(s) |
|
| Subject(s) |
|
| Classification |
|
| Series Title |
|
GMD |
Karya Tulis Ilmiah |
| Language |
Indonesia |
| Publisher |
|
| Publishing Year |
|
| Publishing Place |
|
| Collation |
|
| Abstract/Notes |
ABSTRACT: Pyrazoles and sulfonamides are ubiquitously classified as structural fragments in antimicrobial and
antimycobacterial agents. In this present study, a series of 14 pyrazole based sulfonamide derivatives (7-20) were
designed, synthesized regioisomeric structures were elucidated by spectroscopic methods. All target compounds were
evaluated for their in vitro antibacterial potential against selected Gram (+) and Gram (-) bacterial strains as well as for
their antimycobacterial activity. The bioactivity results demonstrated that all compounds showed selective antibacterial
activity against B. subtilis with MIC values of 1-125 μg/mL. Especially, 1-[(2,4-dichlorophenyl)methyl]-N-(4-
methoxybenzenesulfonyl)-3-methyl-1H-pyrazole-5-carboxamide (9), 1-[(2,4-Dichlorophenyl)methyl]-N-(4-
fluorobenzenesulfonyl)-3-methyl-1H-pyrazole-5-carboxamide (10), N-(3,5-Dichlorobenzenesulfonyl)-1-[(2,4-
dichlorophenyl)methyl]-3-methyl-1H-pyrazole-5-carboxamide (11) and 1-[(2,4-dichlorophenyl)methyl]-N-(4-
fluorobenzenesulfonyl)-5-methyl-1H-pyrazole-3-carboxamide (17) displayed the highest antibacterial activity against
B. subtilis with MIC values of 1 μg/mL, which were more effective compared to the reference chloramphenicol. As a
conclusion, the snythesized new pyrazole sulfonamides stand out as promising antimicrobial agents for further
development.
KEYWORDS: Pyrazole; sulfonamide; regioisomer; antibacterial activity; antimycobacterial activity. |
| Specific Detail Info |
|
| Image |
 |
| File Attachment |
LOADING LIST... |
| Availability |
LOADING LIST... |
| |
Back To Previous |
|